Descriptive Study of Psychiatric Symptoms in White-Sutton Syndrome

Recruiting Observational Study
People With White Sutton Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
6 and older
Sex
Any
Study type
Observational
Participants needed
30 (estimated)
Sponsor
Centre Hospitalier Universitaire Dijon · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
White Sutton syndrome is a rare developmental disorder identified following the description of de novo variations in the POGZ gene, responsible for neurocognitive disorders that may be associated with other signs including hypotonia, deafness, visual disorders, tendency to be overweight, gastrointestinal disorders, convulsions, sleep disorders with sleep apnoea and facial morphological peculiariti…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Individuals with White Sutton syndrome (genetic mutation identified by genetic testing) adults and children, and French speakers * Patient or carer able to complete a questionnaire in French lasting 1 to 2 hours * Age \> 6 years (lower age limit for the primary endpoint) * Con…
Contacts

Raphaëlle MOTTOLESE

03 80 29 53 13

raphaelle.mottolese@chu-dijon.fr

CONTACT